<DOC>
	<DOCNO>NCT00036998</DOCNO>
	<brief_summary>RATIONALE : Microwave thermotherapy kill tumor cell heat several degree body temperature . PURPOSE : Randomized phase II trial compare effectiveness microwave thermotherapy surgery surgery alone treat woman stage I stage II breast cancer .</brief_summary>
	<brief_title>Microwave Thermotherapy Treating Women With Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare safety efficacy preoperative focus microwave thermotherapy follow surgery v surgery alone woman early-stage primary breast cancer . - Compare reduction tumor cell surgical margin second incision rate woman treat regimen . - Compare percentage pathological cell death woman treat regimen . - Compare amount surgically remove breast tumor tissue woman treat regimen . - Compare measurement extent tumor margin surgically remove breast tumor tissue woman treat regimen . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord tumor classification ( T1 v T2 ) participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo ultrasound-guided placement microwave sensor temperature probe ( compression breast ) external placement 2 large oppose microwave emitter 7 skin temperature sensor compress breast . Patients receive focus microwave thermotherapy slowly heats primary breast tumor deep proximal breast tissue . In absence undue heating skin , tumor temperature 48-52Â° C target maintained equivalent thermal dose 140-180 minute . Within 60 day thermotherapy , patient undergo lumpectomy . - Arm II : Patients undergo lumpectomy . Patients follow 30 90 day surgery , discretion physician . PROJECTED ACCRUAL : A total 200-222 patient ( 100-111 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary breast cancer core needle biopsy T1a , b , c , T2 Diagnosis make lumpectomy incisional biopsy Candidate breast conservation surgery ( lumpectomy/radiotherapy ) Tumor measurable breast ultrasound No metastatic disease , include skin metastases No bilateral breast cancer No highprobability extensive intraductal disease situ No clinical fixation pectoralis major muscle skin No involvement nipple No inflammatory breast cancer No multicentric disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Karnofsky 70100 % Life expectancy : At least 6 month Hematopoietic : Platelet count least 100,000/mm^3 ( thrombocytopenia ) No bleed disorder Hepatic : PT , INR , PTT le 1.5 time normal Bilirubin great 2.0 mg/dL Transaminases great 2 time normal No coagulopathy No liver disease Renal : BUN le 30 mg/dL Creatinine le 1.9 mg/dL No renal insufficiency Cardiovascular : No pacemaker defibrillators No clinically significant heart disease Other : Not pregnant nursing Negative pregnancy test Fertile patient must use 2 form effective contraception , include 1 barrier method Able tolerate prone position breast compression No breast implant No prior collagen vascular disease No factor condition ( tumor size ) would preclude lumpectomy No mental condition would preclude study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics Other : No prior participation study More 30 day since prior participation another clinical study No concurrent anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>